Primary objective: To evaluate the efficacy of the cyclosporin A administration to induce a cardioprotection during the valvular surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
56
a single bolus of 2.5 mg/kg, administered before aortic cross-declamping
No cyclosporine A is administered before aortic cross-declamping.
Hôpital Louis Pradel
Lyon, France
The peak of the cardiac troponin I blood level measured during the first 72 hours of surgery follow-up.
Time frame: 72 hours
Area under curve of the cardiac troponin I release, BNP, length of mechanical ventilation, length of stay in ICU, SAPS, necessity of a catecholaminergic support to assure hemodynamic stability, SAE
Time frame: 72 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.